Stage II Prostate Cancer Withdrawn Phase 2 Trials for Docetaxel (DB01248)

Back to Stage II Prostate Cancer

Also known as: Prostate cancer stage II / Prostatic cancer stage II / Carcinoma of the prostate stage II

IndicationStatusPhase
DBCOND0036584 (Stage II Prostate Cancer)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00598858Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the ProstateTreatment